Trends in the Utilization of BRCA1 and BRCA2 Testing After the Introduction of a Publicly Funded Genetic Testing Program.
Simple Summary: When utilized effectively, genetic testing for cancer risk-increasing mutations, (such as pathogenic mutations in the BRCA1 and BRCA2 genes) can identify high-risk individuals prior to cancer development, allowing for tailored interventions aimed at early cancer detection and prevent...
| Publicado en: | Current Oncology Vol. 32; no. 8; pp. 439 - 451 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Aug2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |